Use of predictive probabilities in phase II and phase iii clinical trials

Journal of Biopharmaceutical Statistics

Volumn 9, Issue 1, 1999, Pages 67-79

  Johns, D ^a   Andersen, J S ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Beta binomial distribution; Interim analyses; Therapeutic equivalence

Indexed keywords

ARTICLE; BAYES THEOREM; BIOEQUIVALENCE; DECISION MAKING; DOSE CALCULATION; DRUG DESIGN; PHASE 1 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PREDICTION; PRIORITY JOURNAL; PROBABILITY; STATISTICAL ANALYSIS;

BAYES THEOREM; BINOMIAL DISTRIBUTION; CLINICAL TRIALS, PHASE II; CLINICAL TRIALS, PHASE III; DECISION MAKING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION; HUMANS;

EID: 0032977508     PISSN: 10543406     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIP-100101000     Document Type: Article

References (8)